Suppr超能文献

加利福尼亚州立法者对州卫生政策制定中无党派研究证据使用的制度障碍与促进因素的看法。

Perspectives of California Legislators on Institutional Barriers and Facilitators to Non-Partisan Research Evidence Use in State Health Policymaking.

作者信息

Ashtari Neda, Abbasi Justin, Barnert Elizabeth

机构信息

UCLA David Geffen School of Medicine, Los Angeles, CA, 90024, USA.

Department of Internal Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA.

出版信息

J Gen Intern Med. 2024 Jul;39(9):1704-1712. doi: 10.1007/s11606-023-08547-z. Epub 2023 Dec 15.

Abstract

BACKGROUND

Bridging the translational gap between research evidence and health policy in state legislatures requires understanding the institutional barriers and facilitators to non-partisan research evidence use. Previous studies have identified individual-level barriers and facilitators to research evidence use, but limited perspectives exist on institutional factors within legislatures that influence non-partisan research evidence use in health policymaking.

OBJECTIVE

We describe the perspectives of California state legislators and legislative staff on institutional barriers and facilitators of non-partisan research evidence use in health policymaking and explore potential solutions for enhancing use.

DESIGN

Case study design involving qualitative interviews.

PARTICIPANTS

We interviewed 24 California state legislators, legislative office staff, and legislative research staff.

APPROACH

Semi-structured recorded interviews were conducted in person or by phone to identify opportunities for enhancing non-partisan research evidence use within state legislatures. We conducted thematic analyses of interview transcripts to identify (1) when research evidence is used during the policymaking process, (2) barriers and facilitators operating at the institutional level, and (3) potential solutions for enhancing evidence use.

RESULTS

Institutional barriers to non-partisan research evidence use in health policymaking were grouped into three themes: institutional policies, practices, and priorities. Interviews also revealed institutional-level facilitators of research evidence use, including (1) access and capacity to engage with research evidence, and (2) perceived credibility of research evidence. The most widely supported institutional-level solution for enhancing evidence-based health policymaking in state legislatures involved establishing independent, impartial research entities to provide legislators with trusted evidence to inform decision-making.

CONCLUSIONS

Potential institutional-level changes within state legislatures may enhance evidence use in health policymaking, leading to improved health outcomes and lower healthcare costs for states.

摘要

背景

弥合州立法机构中研究证据与卫生政策之间的转化差距,需要了解无党派研究证据使用的制度障碍和促进因素。以往的研究已经确定了个人层面上研究证据使用的障碍和促进因素,但对于立法机构内部影响卫生政策制定中无党派研究证据使用的制度因素,相关观点有限。

目的

我们描述了加利福尼亚州立法者和立法工作人员对卫生政策制定中无党派研究证据使用的制度障碍和促进因素的看法,并探讨加强使用的潜在解决方案。

设计

采用涉及定性访谈的案例研究设计。

参与者

我们采访了24位加利福尼亚州的立法者、立法办公室工作人员和立法研究人员。

方法

通过面对面或电话进行半结构化录音访谈,以确定在州立法机构内加强无党派研究证据使用的机会。我们对访谈记录进行了主题分析,以确定:(1)在政策制定过程中何时使用研究证据;(2)在机构层面起作用的障碍和促进因素;(3)加强证据使用的潜在解决方案。

结果

卫生政策制定中无党派研究证据使用的制度障碍可归纳为三个主题:制度政策、实践和优先事项。访谈还揭示了研究证据使用的机构层面促进因素,包括:(1)接触和运用研究证据的机会与能力;(2)研究证据的可信度。在州立法机构中,加强循证卫生政策制定最受支持的机构层面解决方案是建立独立、公正的研究实体,为立法者提供可信的证据以辅助决策。

结论

州立法机构内部潜在的制度层面变革可能会加强卫生政策制定中的证据使用,从而改善健康结果并降低各州的医疗成本。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b98/11255140/a8a588103026/11606_2023_8547_Fig1_HTML.jpg

相似文献

本文引用的文献

1
Push, pull or co-produce?推动、拉动还是共同生产?
J Health Serv Res Policy. 2020 Apr;25(2):67-69. doi: 10.1177/1355819620907352.
10
Understanding evidence-based public health policy.理解循证公共卫生政策。
Am J Public Health. 2009 Sep;99(9):1576-83. doi: 10.2105/AJPH.2008.156224. Epub 2009 Jul 16.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验